Systematic Review of the Cost Effectiveness of Dapagliflozin Used to Treat Patients with Type 2 Diabetes Mellitus
May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.503
https://www.valueinhealthjournal.com/article/S1098-3015(18)30803-9/fulltext
Section Title :
Section Order :
1309
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30803-9&doi=10.1016/j.jval.2018.04.503